Literature DB >> 5546412

Management of scleroderma.

R K Winkelmann, R R Kierland, H D Perry, S A Muller, W M Sams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5546412

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  6 in total

1.  Scleroderma presenting with multiple keloids.

Authors:  T A Akintewe; G O Alabi
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

Review 2.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Penicillamine in the treatment of systemic sclerosis.

Authors:  P J Clements
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

4.  Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

Authors:  K D Nolph; L Miller; F C Husted; P Hirszel
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

Review 5.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

6.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.